Moreover, PGRN-overexpressing S1R1 cells showed the ability to overcome temozolomide-induced G2/M phase arrest, where PGRN-depleted cells were unable to recover from temozolomide-induced G2/M phase arrest, clearly indicating the role of PGRN in maintaining tumour cell cycle integrity. This evidence concerns the gene GRN and neoplasm.